Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Trimetazidine manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

trimetazidine

Tablets, sustained release (SR) 20 mg, 35 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20386

This pharmaceutical manufacturing company boasts over four decades of experience in producing and marketing a wide range of products across various therapeutic areas. Specializing in general tablets, hormonal tablets, and oral powders, they cater to markets in both the domestic and international sphere. Their key therapy areas include gastrointestinal disorders, cardiovascular health, urology, allergy treatment, contraception, and hormone replacement therapy. With a focus on quality and cost-effectiveness, they provide comprehensive service support to a loyal customer base spanning regions like North America and the EU.

Manufacturer usually replies in 9 days

trimetazidine

Tablets for oral solution 35 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19884
This pharmaceutical company, established in 1962, specializes in developing, manufacturing, and distributing a wide range of cost-effective pharmaceuticals. They are known for their commitment to patient well-being, particularly those with rare diseases. Their product portfolio includes prescription medications, over-the-counter drugs, and supplements. Key therapy areas include women's health, pain management, and gastrointestinal disorders. Principal dosage forms include tablets, capsules, and liquids. While specific GMP certifications and patent information are not provided, their products are distributed across regions such as the EU and North America.

trimetazidine

Tablets, sustained release (SR) 35mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19412
This pharmaceutical group is experiencing rapid growth, increasing its turnover from Rs. 1.5 crores in 2006 to Rs. 12 crores by 2009-2010 and aiming for Rs. 50 crores by 2015. While specific product details are not provided, the company operates across diverse therapeutic areas with a focus on both prescription medications and over-the-counter drugs. They highlight their management team's vision and dynamism, suggesting strong leadership driving their expansion within India.

Manufacturer usually replies in 51 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.